Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: A clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors

被引:104
作者
Kimura, Noriko
Watanabe, Toshiya
Noshiro, Takao
Shizawa, Soichiro
Miura, Yukio
机构
[1] Tohoku Rosai Hosp, Japan Labor Hlth & Welf Org, Dept Pathol & Lab Med, Aoba Ku, Sendai, Miyagi 9818563, Japan
[2] Tohoku Univ, Sch Med, Dept Internal Med 2, Sendai, Miyagi 980, Japan
[3] Natl Nishitaga Hosp, Dept Med, Sendai, Miyagi, Japan
关键词
pheochromocytoma; paraganglioma; malignant; grading; metastasis; prognosis;
D O I
10.1385/EP:16:1:023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pheochromocytomas and extra-adrenal sympathetic paragangliomas show varied histological patterns, and it is difficult to diagnose malignancy or predict the clinical course using current histological criteria. In the present study, we reviewed 146 sympathetic paragangliomas including 116 adrenal (102 unilateral, 14 bilateral) and 30 extra-adrenal tumors including 38 metastatic tumors. We developed a scoring scale according to the following six factors: histological pattern, cellularity, coagulation necrosis, vascular/capsular invasion, Ki-67 immunoreactivity, and types of catecholamine produced. The tumors were classified as well (WD), moderately (MD), and poorly differentiated (PD) types according to their scores. The frequency of these tumor types were 113 WD (77%), 27 MD (19%), and 6 PD (4%). Metastasis was observed in 15 of 113 WD (13%), 17 of 27 MD (63%), and all 6 PD (100%). Five-year survivals of patients with metastases were 92% with WD, 69% with MD, 0% with PD. Respective 10-yr survivals were 83%, 38%, and 0%. Differences between groups were statistically significant. The data show that using this grading scoring system for sympathetic paragangliomas correlates with both metastatic potential and patient survival.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 23 条
[1]   Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas [J].
Dannenberg, H ;
Komminoth, P ;
Dinjens, WNM ;
Speel, EJM ;
de Krijger, RR .
ENDOCRINE PATHOLOGY, 2003, 14 (04) :329-350
[2]  
DELELLIS RA, 1986, TUMORS ADRENAL, P203
[3]   Deficiency of phenylethanolamine N-methyltransferase in norepinephrine-producing pheochromocytoma [J].
Kimura, N ;
Togo, A ;
Sugimoto, T ;
Nata, K ;
Okamoto, H ;
Nagatsu, I ;
Nagura, H .
ENDOCRINE PATHOLOGY, 1996, 7 (02) :131-136
[4]   CATECHOLAMINE SYNTHESIZING ENZYMES IN 70 CASES OF FUNCTIONING AND NONFUNCTIONING PHEOCHROMOCYTOMA AND EXTRAADRENAL PARAGANGLIOMA [J].
KIMURA, N ;
MIURA, Y ;
NAGATSU, I ;
NAGURA, H .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1992, 421 (01) :25-32
[5]   KI-67 IS AN INDICATOR OF PROGRESSION OF NEUROENDOCRINE TUMORS [J].
KIMURA, N ;
MIURA, W ;
NOSHIRO, T ;
MIURA, Y ;
OOKUMA, T ;
NAGURA, H .
ENDOCRINE PATHOLOGY, 1994, 5 (04) :223-228
[6]  
KIMURA N, 1990, ENDOCR PATHOL, V1, P99
[7]  
KIMURA N, 2000, MOL CELL ENDOCRINOL, P253
[8]  
Kimura N, 2004, WHO CLASSIFICATION T, P164
[9]  
LINNOILA RI, 1990, HUM PATHOL, V21, P1168
[10]  
LLOYD RV, 1985, ARCH PATHOL LAB MED, V109, P633